358 related articles for article (PubMed ID: 19182090)
1. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
van Walraven C; Hart RG; Connolly S; Austin PC; Mant J; Hobbs FD; Koudstaal PJ; Petersen P; Perez-Gomez F; Knottnerus JA; Boode B; Ezekowitz MD; Singer DE
Stroke; 2009 Apr; 40(4):1410-6. PubMed ID: 19182090
[TBL] [Abstract][Full Text] [Related]
2. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.
RAF and RENO-EXTEND Investigators*
Eur Stroke J; 2023 Sep; 8(3):722-730. PubMed ID: 37458099
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
[TBL] [Abstract][Full Text] [Related]
5. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
6. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P
Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996
[TBL] [Abstract][Full Text] [Related]
7. Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.
Paciaroni M; Agnelli G; Falocci N; Caso V; Becattini C; Marcheselli S; Rueckert C; Pezzini A; Poli L; Padovani A; Csiba L; Szabó L; Sohn SI; Tassinari T; Abdul-Rahim AH; Michel P; Cordier M; Vanacker P; Remillard S; Alberti A; Venti M; Scoditti U; Denti L; Orlandi G; Chiti A; Gialdini G; Bovi P; Carletti M; Rigatelli A; Putaala J; Tatlisumak T; Masotti L; Lorenzini G; Tassi R; Guideri F; Martini G; Tsivgoulis G; Vadikolias K; Liantinioti C; Corea F; Del Sette M; Ageno W; De Lodovici ML; Bono G; Baldi A; D'Anna S; Sacco S; Carolei A; Tiseo C; Acciarresi M; D'Amore C; Imberti D; Zabzuni D; Doronin B; Volodina V; Consoli D; Galati F; Pieroni A; Toni D; Monaco S; Baronello MM; Barlinn K; Pallesen LP; Kepplinger J; Bodechtel U; Gerber J; Deleu D; Melikyan G; Ibrahim F; Akhtar N; Mosconi MG; Bubba V; Silvestri I; Lees KR
Stroke; 2015 Aug; 46(8):2175-82. PubMed ID: 26130094
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Adding Antiplatelets to Oral Anticoagulants in Patients with Acute Ischemic Stroke with Atrial Fibrillation and Concomitant Large Artery Steno-Occlusion.
Kim JT; Lee JS; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Park MS; Choi KH; Cho KH; Lee J; Gorelick PB; Bae HJ
Transl Stroke Res; 2020 Dec; 11(6):1322-1331. PubMed ID: 32472251
[TBL] [Abstract][Full Text] [Related]
9. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation.
Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP
JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036
[TBL] [Abstract][Full Text] [Related]
10. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
11. Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation?
McGrath ER; Kapral MK; Fang J; Eikelboom JW; ó Conghaile A; Canavan M; O'Donnell MJ;
Stroke; 2012 Aug; 43(8):2048-54. PubMed ID: 22618379
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
[TBL] [Abstract][Full Text] [Related]
13. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
Alexander JH; Wojdyla D; Vora AN; Thomas L; Granger CB; Goodman SG; Aronson R; Windecker S; Mehran R; Lopes RD
Circulation; 2020 May; 141(20):1618-1627. PubMed ID: 32223444
[TBL] [Abstract][Full Text] [Related]
14. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
[TBL] [Abstract][Full Text] [Related]
15. Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Blann AD; Skjøth F; Rasmussen LH; Larsen TB; Lip GY
Thromb Haemost; 2015 Aug; 114(2):403-9. PubMed ID: 26062437
[TBL] [Abstract][Full Text] [Related]
16. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
[TBL] [Abstract][Full Text] [Related]
17. Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation.
Fox KAA; Velentgas P; Camm AJ; Bassand JP; Fitzmaurice DA; Gersh BJ; Goldhaber SZ; Goto S; Haas S; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Dabrowski E; Luo K; Gibbs L; Kakkar AK;
JAMA Netw Open; 2020 Feb; 3(2):e200107. PubMed ID: 32101311
[TBL] [Abstract][Full Text] [Related]
18. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
19. Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.
Tentschert S; Parigger S; Dorda V; Bittner K; Unterbuchschachner D; Greisenegger S; Wimmer R; Brücke T; Lang W; Lalouschek W;
Wien Klin Wochenschr; 2004 Dec; 116(24):834-8. PubMed ID: 15690967
[TBL] [Abstract][Full Text] [Related]
20. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
